128 related articles for article (PubMed ID: 16971117)
41. Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists.
Shah U; Boyle CD; Chackalamannil S; Neustadt BR; Lindo N; Greenlee WJ; Foster C; Arik L; Zhai Y; Ng K; Wang S; Monopoli A; Lachowicz JE
Bioorg Med Chem Lett; 2008 Jul; 18(14):4199-203. PubMed ID: 18562199
[TBL] [Abstract][Full Text] [Related]
42. 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
Lambertucci C; Antonini I; Buccioni M; Dal Ben D; Kachare DD; Volpini R; Klotz KN; Cristalli G
Bioorg Med Chem; 2009 Apr; 17(7):2812-22. PubMed ID: 19282184
[TBL] [Abstract][Full Text] [Related]
43. Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity.
Ayesa S; Lindquist C; Agback T; Benkestock K; Classon B; Henderson I; Hewitt E; Jansson K; Kallin A; Sheppard D; Samuelsson B
Bioorg Med Chem; 2009 Feb; 17(3):1307-24. PubMed ID: 19124252
[TBL] [Abstract][Full Text] [Related]
44. Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines.
Neustadt BR; Hao J; Lindo N; Greenlee WJ; Stamford AW; Tulshian D; Ongini E; Hunter J; Monopoli A; Bertorelli R; Foster C; Arik L; Lachowicz J; Ng K; Feng KI
Bioorg Med Chem Lett; 2007 Mar; 17(5):1376-80. PubMed ID: 17236762
[TBL] [Abstract][Full Text] [Related]
45. Discovery of small molecule human C5a receptor antagonists.
Sanganee HJ; Baxter A; Barber S; Brown AJ; Grice D; Hunt F; King S; Laughton D; Pairaudeau G; Thong B; Weaver R; Unitt J
Bioorg Med Chem Lett; 2009 Feb; 19(4):1143-7. PubMed ID: 19171482
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists.
Yao G; Haque S; Sha L; Kumaravel G; Wang J; Engber TM; Whalley ET; Conlon PR; Chang H; Kiesman WF; Petter RC
Bioorg Med Chem Lett; 2005 Feb; 15(3):511-5. PubMed ID: 15664803
[TBL] [Abstract][Full Text] [Related]
47. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
[TBL] [Abstract][Full Text] [Related]
48. Synthesis of a series of 8-(substituted-phenyl)xanthines and a study on the effects of substitution pattern of phenyl substituents on affinity for adenosine A(1) and A(2A) receptors.
Bansal R; Kumar G; Gandhi D; Young LC; Harvey AL
Eur J Med Chem; 2009 May; 44(5):2122-7. PubMed ID: 19036477
[TBL] [Abstract][Full Text] [Related]
49. Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines.
Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Jordan AM; Knight AR; Lerpiniere J; Misra A; Pratt RM; Roffey J; Stratton GC; Upton R; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2924-9. PubMed ID: 18411049
[TBL] [Abstract][Full Text] [Related]
50. Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists.
Shook BC; Chakravarty D; Barbay JK; Wang A; Leonard K; Alford V; Powell MT; Rassnick S; Scannevin RH; Carroll K; Wallace N; Crooke J; Ault M; Lampron L; Westover L; Rhodes K; Jackson PF
Bioorg Med Chem Lett; 2013 May; 23(9):2688-91. PubMed ID: 23522563
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists.
Shah U; Lankin CM; Boyle CD; Chackalamannil S; Greenlee WJ; Neustadt BR; Cohen-Williams ME; Higgins GA; Ng K; Varty GB; Zhang H; Lachowicz JE
Bioorg Med Chem Lett; 2008 Jul; 18(14):4204-9. PubMed ID: 18558486
[TBL] [Abstract][Full Text] [Related]
52. Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human H3-receptor.
Peschke B; Bak S; Hohlweg R; Nielsen R; Viuff D; Rimvall K
Bioorg Med Chem Lett; 2006 Jun; 16(12):3162-5. PubMed ID: 16616493
[TBL] [Abstract][Full Text] [Related]
53. Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
Marino JP; Fisher PW; Hofmann GA; Kirkpatrick RB; Janson CA; Johnson RK; Ma C; Mattern M; Meek TD; Ryan MD; Schulz C; Smith WW; Tew DG; Tomazek TA; Veber DF; Xiong WC; Yamamoto Y; Yamashita K; Yang G; Thompson SK
J Med Chem; 2007 Aug; 50(16):3777-85. PubMed ID: 17636946
[TBL] [Abstract][Full Text] [Related]
54. Extended aromatic furan amidino derivatives as anti-Pneumocystis carinii agents.
Hopkins KT; Wilson WD; Bender BC; McCurdy DR; Hall JE; Tidwell RR; Kumar A; Bajic M; Boykin DW
J Med Chem; 1998 Sep; 41(20):3872-8. PubMed ID: 9748362
[TBL] [Abstract][Full Text] [Related]
55. 3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists.
Wei J; Wang S; Gao S; Dai X; Gao Q
J Chem Inf Model; 2007; 47(2):613-25. PubMed ID: 17330954
[TBL] [Abstract][Full Text] [Related]
56. Highlights on the development of A(2A) adenosine receptor agonists and antagonists.
Cristalli G; Cacciari B; Dal Ben D; Lambertucci C; Moro S; Spalluto G; Volpini R
ChemMedChem; 2007 Mar; 2(3):260-81. PubMed ID: 17177231
[TBL] [Abstract][Full Text] [Related]
57. N-[6-amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A receptor antagonists with improved drug like properties and in vivo efficacy.
Lanier MC; Moorjani M; Luo Z; Chen Y; Lin E; Tellew JE; Zhang X; Williams JP; Gross RS; Lechner SM; Markison S; Joswig T; Kargo W; Piercey J; Santos M; Malany S; Zhao M; Petroski R; Crespo MI; Díaz JL; Saunders J; Wen J; O'Brien Z; Jalali K; Madan A; Slee DH
J Med Chem; 2009 Feb; 52(3):709-17. PubMed ID: 19140664
[TBL] [Abstract][Full Text] [Related]
58. 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.
Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Westerhout J; Spangenberg T; Brussee J; Ijzerman AP
J Med Chem; 2007 Feb; 50(4):828-34. PubMed ID: 17300165
[TBL] [Abstract][Full Text] [Related]
59. A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.
van Veldhoven JP; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Struensee-Link R; Beukers MW; Brussee J; IJzerman AP
Bioorg Med Chem; 2008 Mar; 16(6):2741-52. PubMed ID: 18258439
[TBL] [Abstract][Full Text] [Related]
60. De novo design of nonpeptidic compounds targeting the interactions between interferon-alpha and its cognate cell surface receptor.
Bello AM; Bende T; Wei L; Wang X; Majchrzak-Kita B; Fish EN; Kotra LP
J Med Chem; 2008 May; 51(9):2734-43. PubMed ID: 18393399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
